Alan Neiberg
Internal Medicine · Lansing, MINPI 1710939806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 204 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,327 and has fallen 98.9% since, to $14 in 2023.
Across 204 payments — averaging $12.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$292
- Amgen$289
- Lilly USA, LLC$229
- Novo Nordisk$202
- Merck$199
- Novartis$184
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,597100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $292 |
| Amgen | 20 | $289 |
| Lilly USA, LLC | 25 | $229 |
| Novo Nordisk | 16 | $202 |
| Merck | 16 | $199 |
| Novartis | 13 | $184 |
| GSK | 20 | $179 |
| Boehringer Ingelheim | 8 | $133 |
| Amarin Pharma, Inc. | 7 | $104 |
| Melinta Therapeutics, LLC | 6 | $103 |
| Astellas Pharma US Inc | 5 | $92 |
| AbbVie | 6 | $78 |
| Johnson & Johnson | 5 | $72 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Jazz Pharmaceuticals Inc. | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Phadia US Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 2 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| AstraZeneca | 1 | $17 |
| UCB, Inc. | 1 | $15 |
| Gilead | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Boston Scientific | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $11 |
How this compares
$2,605 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Lansing
- Miki YokokawaLansing$84K
- Robert GumbitaLansing$63K
- Khader HerzallahLansing$54K
- Christopher AlvaradoLansing$35K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.